Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04014179
NA

Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Programs

Sponsor: Kirby Institute

View on ClinicalTrials.gov

Summary

This project aims to evaluate two strategies of Hepatitis C virus (HCV) testing compared to standard of care among people who inject drugs at needle and syringe program (NSP) services in Australia, to see if it can improve the number of people who start treatment following an HCV diagnosis: 1. HCV testing from collected dried blood spots sent to a central laboratory 2. HCV testing using a point-of-care device at the NSP site 3. HCV testing using standard of care at the NSP site

Official title: A Multi-centre, Practice-level, Cluster Randomized Controlled Trial to Compare Point-of-care HCV RNA Testing, Dried Blood Spot Testing, and Standard of Care to Enhance Treatment Uptake Among People With HCV Who Have Recently Injected Drugs Attending Needle and Syringe Programs: the TEMPO Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

2700

Start Date

2022-07-27

Completion Date

2026-07-31

Last Updated

2025-07-17

Healthy Volunteers

Yes

Interventions

DIAGNOSTIC_TEST

Xpert HCV Viral Load Fingerstick

The Cepheid Xpert HCV Viral Load (VL) Fingerstick assay is an in vitro nucleic acid amplification test designed for the quantitation of Hepatitis C Virus (HCV) DNA in human whole blood using the automated GeneXpert Systems. The HCV RNA result from the Xpert test will be used to initiate HCV treatment.

DIAGNOSTIC_TEST

Aptima HCV Quant DX Assay

The Aptima HCV Quant Dx assay is a real-time transcription-mediated amplification test. The assay is used for both detection and quantitation of hepatitis C virus (HCV) RNA in fresh and frozen human serum and plasma from HCV-infected individuals, and in this study from dried blood spots. The HCV RNA result from the Aptima assay will be used to initiate HCV treatment.

Locations (17)

Bankstown NSP

Bankstown, New South Wales, Australia

WSLHD Drug Health - Blacktown NSP

Blacktown, New South Wales, Australia

Coffs Harbour Primary NSP

Coffs Harbour, New South Wales, Australia

Gosford NSP

Gosford, New South Wales, Australia

Grafton Primary NSP

Grafton, New South Wales, Australia

Kempsey Primary NSP

Kempsey, New South Wales, Australia

Liverpool Southwest NSP

Liverpool, New South Wales, Australia

WSLHD Drug Health - Mt Druitt NSP

Mount Druitt, New South Wales, Australia

Orana Centre

Wollongong, New South Wales, Australia

Alcohol and Drug Harm Reduction Biala

Brisbane, Queensland, Australia

Severin St NSP (Youth Link)

Cairns, Queensland, Australia

Inala

Inala, Queensland, Australia

Kobi House

Toowoomba, Queensland, Australia

UC Adelaide

Adelaide, South Australia, Australia

Wonggangga Turtpandi Aboriginal Primary Health Care Services

Adelaide, South Australia, Australia

Northern DASSA

Elizabeth, South Australia, Australia

Noarlunga Health Precinct

Old Noarlunga, South Australia, Australia